LYCOS RETRIEVER 
Financing: Programs
built 623 days ago
Proceeds from this financing will be used to accelerate Sirtris' therapeutic programs, particularly those focused on metabolic and neurological diseases. "Sirtuins are emerging as attractive targets in diseases ranging from metabolic to neurological disorders, and Sirtris is poised to lead the development of therapeutics in this area," said Brad Gray, Director, Corporate Development at Genzyme and leader of Genzyme Ventures. In conjunction with the Series C transaction, Stephen Kraus, representing Bessemer Venture Partners, will join Sirtris' Board of Directors. "Sirtris' leadership in the science of sirtuins provides a fundamental biological platform for the development of therapeutic products across multiple disease areas," said Kraus.
Source:
You'll receive periodic news about financing and notices when special programs become available. Your privacy is always protected and your information will never be revealed to anyone. Of course you can unsubscribe at any time.
Source:
The first tranche of the financing closed in October 2006 and resulted in gross proceeds of approximately $26.7 million. Memory Pharmaceuticals intends to use the net proceeds from both tranches of the financing to advance its clinical, preclinical and exploratory research programs and for other working capital and general corporate purposes.
Source:
The minimum or maximum amount of an initial financing agreement is set at a program level. For more information, please refer to the individual program for the country of interest at Microsoft Financing.
Source:
"Securing the best financing for our customers is a key advantage of our SunPower Access program," said Tom Werner, chief executive officer of SunPower. "This agreement with Morgan Stanley offers our customers a more efficient and cost-competitive process to realize the financial savings and environmental benefits of solar power."
Source:
WILMINGTON, Del., Feb. 5 /PRNewswire-FirstCall/ -- Heritage Capital Credit Corporation HCPC today announced that it is arranging short-term financing of $170 million for a commercial revenue producing project. An independent third party lender has issued the letter of interest for financing and anticipates scheduling the closing upon completion of its due diligence. This financing is expected to ultimately roll into the BCLOC program.
Source:
MORE ABOUT
Programs